OXEYE, NCT05697809: Suprachoroidal Sustained-Release OXU-001 Compared to Intravitreal Ozurdex® in the Treatment of Diabetic Macular Edema |
|
|
| Active, not recruiting | 2 | 3 | US | OXU-001, DEXAspheres®, Semi-automated suprachoroidal illuminated microcatheter, Oxulumis®, Ozurdex® Ophthalmic Intravitreal Implant, intravitreal dexamethasone implant | Oxular Limited | Diabetic Macular Edema | 11/24 | 03/25 | | |
